SAG and respiratory depression: In fact, functional studies revealed a G protein biased signaling of cebranopadol at the NOP and at a reduced degree at the MOP receptor.6 Reduced ß‐arrestin recruitment and preferred G protein activation are discussed as contributor for reduction of opioid‐type side effects such as respiratory depression and gastrointestinal dysfunction.29